Neurology Archives - Page 2 of 10

PANORAMA: A 2021 clinician survey of treatment approaches for people with new diagnoses of relapsing-remitting multiple sclerosis in the United Kingdom

Authors: N Evangelou, M Mattoscio, M Coutts, M Andiappan, T Sawtell, K Rhys Published: International Journal of MS Care, 2025 View publication Background The PANORAMA survey aimed to assess current treatment practice...

Post-hoc assessment of cognitive efficacy in Alzheimer’s disease using a latent growth mixture model in AMBAR, a phase 2B randomized controlled trial

Authors: N D Ayasse, W F Stewart, R B Lipton, D Gomez-Ulloa, M C Runken Published: Current Alzheimer Research, 2025 View publication Background Disease progression in Alzheimer’s Dementia (AD) is typically characterized...

Symptoms across the phases of the migraine cycle from the patient’s perspective: Results of the MiCOAS qualitative study

Authors: J S McGinley, R Mangrum, M T Gerstein, K P McCarrier, C R Houts, D C Buse, A L Bryant, R J Wirth, R B Lipton Published: Headache, 2025 View publication...

A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in England

Authors: J van Enkhuizen, J Binns, A Betts, F S Hosnijeh, M Alexander, M McCormack, S Jacob Published: Therapeutic Advances in Neurological Disorders, 2024 View publication Background There are limited data on...

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries

Authors: O Zaidi, F Du, Z Tang, S Bhattacharjee & K Pareja Published: BMC Nephrology, 2024 View publication Background Immunoglobulin type A (IgA) nephropathy is the most common primary glomerulonephritis (GN) worldwide...

Physician and professional caregiver perspectives on meaningful change to agitation behaviors in alzheimer’s dementia: insights from qualitative interviews

Authors: J Smith, B Talon, A Pena-Molina, K McCarrier, J Aggarwal Published: The American Journal of Geriatric Psychiatry, 2024 View publication Introduction Agitation is a common neuropsychiatric symptom of Alzheimer’s dementia (AD)....

Cost effectiveness of fremanezumab in episodic and chronic migraine patients from a Japanese healthcare perspective

Authors: T Takeshima, F Sakai, X Wang, K Yamato, Y Kojima, Y Zhang, C Bennison & M J H G Simons Published: PharmacoEconomics, 2024 View publication Background and Objectives Fremanezumab is an...

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine

Authors: R Mangrum, A L Bryant, M T Gerstein, K P McCarrier, C R Houts, J S McGinley, D C Buse, R B Lipton, R J Wirth Published: Headache, 2024 View publication...

Real-world use of Ubrogepant as acute treatment for migraine with an anti-calcitonin gene-related peptide monoclonal antibody: results from COURAGE

Authors: R B Lipton, J Contreras-De Lama, D Serrano, E Engstrom, N D Ayasse, W Poh, F Cadiou, A M Adams Published: Neurology and Therapy, 2023 View publication Introduction Although acute and...

News